Inventor · disambiguated record
Mark Tepper
Also filed as: TEPPER MARK · TEPPER MARK A · TEPPER MARK ALLAN
16 granted patents·12 pending applications·68 citations·filing 1994–2021
92Inventor score
Files withCORBUS PHARMACEUTICALS INC11APPLIED RESEARCH SYSTEMS5MERCK SERONO SA2BRIGHAM & WOMENS HOSPITAL INC1BRISTOL MYERS SQUIBB CO1
Top patents by PatentIndex Score
28 records- 0188US9820964B2Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2016·Granted Nov 21, 2017·5 cites·21 claims
- 0288US7078236B2Methods of inducing ovulationAPPLIED RESEARCH SYSTEMS·Filed 2005·Granted Jul 18, 2006·5 cites·17 claims
- 0384US10154986B2Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2017·Granted Dec 18, 2018·3 cites·16 claims
- 0483US6953774B2Methods of inducing ovulationAPPLIED RESEARCH SYSTEMS·Filed 2001·Granted Oct 11, 2005·12 cites·3 claims
- 0578US10369131B2Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2018·Granted Aug 6, 2019·1 cites·16 claims
- 0677US9801849B2Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2016·Granted Oct 31, 2017·1 cites·18 claims
- 0776US11052066B2Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2019·Granted Jul 6, 2021·0 cites·18 claims
- 0875US10085964B2Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2016·Granted Oct 2, 2018·1 cites·19 claims
- 0975US2022117931A1Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1073US7803760B2Methods of inducing ovulationMERCK SERONO SA·Filed 2008·Granted Sep 28, 2010·0 cites·24 claims
- 1169US10470979B2Intelligent pacifierHIVE DESIGN INC·Filed 2017·Granted Nov 12, 2019·4 cites·20 claims
- 1267US7364910B2Methods of inducing ovulationAPPLIED RESEARCH SYSTEMS·Filed 2006·Granted Apr 29, 2008·0 cites·4 claims
- 1365US2015141501A1Ultrapure tetrahydrocannabinol-11-oic acidsCORBUS PHARMACEUTICS INC·Filed 2014·Application pending·0 cites
- 1463US7700112B2FSH beta mutants that are glycosilated at residues N55 and T57MERCK SERONO SA·Filed 2004·Granted Apr 20, 2010·2 cites·12 claims
- 1560US7507707B2Methods of inducing ovulation using a non-polypeptide camp level modulatorSERONO LAB·Filed 2001·Granted Mar 24, 2009·1 cites·15 claims
- 1658US2020405687A1Methods for the treatment of infectionCORBUS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1754US6372207B1IFNAR2/IFN complexAPPLIED RESEARCH SYSTEMS·Filed 1998·Granted Apr 16, 2002·9 cites·28 claims
- 1854US5505715AIontophoretic transdermal delivery of deoxyspergualin compoundsBRISTOL MYERS SQUIBB CO·Filed 1994·Granted Apr 9, 1996·10 cites·27 claims
- 1954US2023218548A1Nitro-aminoadamantane compounds for the treatment of betacoronavirus infectionsEUMENTIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2054US2013338220A1Compositions, dosages, and methods of using tetrahydrocannabinol derivativesTEPPER MARK·Filed 2011·Application pending·0 cites
- 2153US6337316B1Pharmaceutical compositions thereof, and methods of using sameAPPLIED RESEARCH SYSTEMS·Filed 1999·Granted Jan 8, 2002·14 cites·6 claims
- 2253US2017022179A1Compositions, dosages, and methods of using tetrahydrocannabinol derivativesCORBUS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2348US2017124586A1Systems and methods for providing a personalized prepaid cardReferral Rewards LLC·Filed 2016·Application pending·0 cites
- 2446US2019133995A1Methods for the treatment of infectionCORBUS PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2544US2021401798A1Lipoxin a4 analogs and uses thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2019·Application pending·0 cites
- 2644US2002065324A1Methods of inducing ovulationFiled 2001·Application pending·0 cites
- 2742US2021284621A1Cannabinoids and uses thereofCORBUS PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 2836US2007015720A1Modulation of endogenous AICAR levels for the treatment of diabetes and obesityCYTRX CORP·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →